A retrospective analysis using deep-learning models for prediction of survival outcome and benefit of adjuvant chemotherapy in stage II/III colorectal cancer

Xingyu Li,Jitendra Jonnagaddala,Shuhua Yang,Hong Zhang,Xu Steven Xu
DOI: https://doi.org/10.1007/s00432-022-03976-5
2022-03-24
Journal of Cancer Research and Clinical Oncology
Abstract:Most of Stage II/III colorectal cancer (CRC) patients can be cured by surgery alone, and only certain CRC patients benefit from adjuvant chemotherapy. Risk stratification based on deep-learning from haematoxylin and eosin (H&E) images has been postulated as a potential predictive biomarker for benefit from adjuvant chemotherapy. However, very limited success has been achieved in using biomarkers, including deep-learning-based markers, to facilitate the decision for adjuvant chemotherapy despite recent advances of artificial intelligence.
oncology
What problem does this paper attempt to address?